Alnylam Pharmaceuticals · 1 day ago
Director, Financial Planning & Analysis
Cambridge, MA
Part-time
Onsite
Director/Executive
$196K/yr - $264K/yr
10+ years expAlnylam Pharmaceuticals is seeking a part-time Director of Alliance & Strategic Finance Optimization, who will serve as a strategic finance leader within the Alliance & Business Development Finance team. The Director will play a critical role in enabling effective decision-making for collaborations and strengthening financial processes across various functions.
BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Responsibilities
Drive special projects and develop actionable recommendations for the Executive Leadership Team (ELT) with clear, data-driven insights that support strategic and operational decisions
Partner with cross-functional leaders to align financial insights with enterprise goals and enhance decision-making across R&D, Technical Operations, and Commercial functions
Lead benchmarking and performance analysis projects to evaluate efficiency, productivity, and competitiveness across the business
Manage sensitive and high-impact deliverables in partnership with senior Finance and business leaders
Deliver ad hoc financial analyses and assessments for key existing alliances and partnerships, supporting strategic reviews, business cases, and long-range planning
Provide oversight and leadership to BD and Alliance FP&A team members supporting business case development for both existing and prospective partnerships
Support the financial integration of new partnerships and business opportunities, working closely with Alliance Management and other cross-functional stakeholders
Collaborate with Legal, Technical Accounting, Tax, and Treasury to ensure a comprehensive financial perspective across both new and existing external collaborations
Provide oversight for partnership governance forums and related finance deliverables, including annual budget and forecast processes
Contribute to internal financial planning cycles as they relate to existing and new partnerships
Drive continuous improvement initiatives to enhance processes, systems, and reporting frameworks supporting BD and Alliance Finance activities
Serve as a flexible resource to support and coach Alliance & BD Finance team members on advanced financial modeling, valuation, and scenario planning
Contribute to the development and continuous improvement of tools, templates, and best practices that elevate analytical rigor and consistency across the Finance organization
Qualification
Required
Bachelor's Degree in Finance or other degrees with quantitative focus (e.g. Statistics, Econometrics, Mathematics) required
MBA and/or other advanced degree is a plus
A minimum of 10+ years of experience in finance or a related field, preferably with a focus on Alliance / Program Management or Business Development Finance or strategic planning in life sciences
Strong understanding of drug discovery, development, manufacturing, regulatory, and commercialization
Demonstrated success in leading process improvement and change management initiatives
Excellent communication and presentation skills, with the ability to influence stakeholders at all levels and a proven ability to present complex financial insights to senior stakeholders
Strong understanding of financial models, valuations, and business proposals
Demonstrated ability to translate complex financial information and assumptions into effective presentations
Excellent time management and ability to prioritize and remain organized in fast-paced, dynamic environment
Expertise with Excel and PowerPoint
Intellectually curious and willing to offer insights or challenge assumptions appropriately
Strong collaboration skills, with an ability to inspire and motivate teams
Excellent analytical, strategic planning, and problem-solving skills
Ability to work as a member of the deal team, as well as an individual contributor
Exceptional attention to detail
Ability to influence and build relationships at all levels of the organization
Benefits
Comprehensive benefits including medical, dental, and vision coverage
Life and disability insurance
Lifestyle reimbursement program
Flexible spending and health savings accounts
401(k) with a generous company match
Paid time off
Wellness days
Holidays
Two company-wide recharge breaks
Generous family resources and leave
Company
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$4.55BKey Investors
Blackstone Life SciencesBlackstone CreditRegeneron
2025-09-09Post Ipo Debt· $661.25M
2022-09-12Post Ipo Debt· $900M
2022-03-04IPO
Leadership Team
Yvonne Greenstreet
Chief Executive Officer
Jeff Poulton
Chief Financial Officer
Recent News
Clinical Trials Arena
2026-01-16
Longevity.Technology
2026-01-14
2026-01-13
Company data provided by crunchbase